JPMorgan Chase & Co’s Vicarious Surgical RBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$661 Buy
88
+7
+9% +$53 ﹤0.01% 5778
2025
Q1
$531 Sell
81
-3,450
-98% -$22.6K ﹤0.01% 5821
2024
Q4
$46.5K Buy
3,531
+2,044
+137% +$26.9K ﹤0.01% 5037
2024
Q3
$8.45K Buy
1,487
+1,406
+1,736% +$7.99K ﹤0.01% 5348
2024
Q2
$475 Sell
81
-4,054
-98% -$23.8K ﹤0.01% 5668
2024
Q1
$37.4K Buy
4,135
+1,304
+46% +$11.8K ﹤0.01% 5065
2023
Q4
$31.1K Buy
2,831
+1,313
+86% +$14.4K ﹤0.01% 5145
2023
Q3
$26.9K Sell
1,518
-347
-19% -$6.15K ﹤0.01% 5074
2023
Q2
$102K Buy
1,865
+450
+32% +$24.7K ﹤0.01% 4620
2023
Q1
$96K Buy
1,415
+382
+37% +$25.9K ﹤0.01% 4667
2022
Q4
$62K Buy
1,033
+39
+4% +$2.34K ﹤0.01% 4662
2022
Q3
$100K Buy
994
+22
+2% +$2.21K ﹤0.01% 4470
2022
Q2
$86K Buy
972
+281
+41% +$24.9K ﹤0.01% 4695
2022
Q1
$105K Sell
691
-264
-28% -$40.1K ﹤0.01% 4721
2021
Q4
$304K Buy
+955
New +$304K ﹤0.01% 4330